Epilan Tablets (Sodium Valproate)

Adult dose

Adults: Administer 400-1200㎎ of sodium valproate daily orally in 2-3 divided doses. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in pregnant women except in special cases. Women of childbearing potential should strictly adhere to a pregnancy prevention program before taking this medication. Care should be taken when using this medication along with hormonal contraceptives containing estrogen, as it may lower the blood concentration of this medication. During the use of this medication, mental health conditions such as suicidal thoughts or actions and depression should be carefully monitored. Patients with liver or pancreatic dysfunction should not take this medication, and if symptoms of liver damage or pancreatitis appear, medical personnel should be notified immediately. Special care should be taken when administering this medication alone to children under the age of 3, and concomitant use with salicylate derivatives should be avoided. Regular liver function tests are required while taking this medication, particularly periodic testing is crucial during the first 6 months. Blood tests are also necessary, and extra caution should be exercised if there is thrombocytopenia or a tendency for bleeding. Do not suddenly stop taking the medication, and any dosage adjustments should be discussed with medical personnel. This medication has many drug interactions, so if you are taking any other medications, you must inform medical personnel. Care should also be taken when taking it with alcohol or other central nervous system depressants, as it can exacerbate drowsiness or central nervous system suppression symptoms. Women who are planning a pregnancy or who may become pregnant should consult with medical personnel before taking this medication and should use effective contraceptive methods. Breastfeeding women should also consult with medical personnel before deciding to take this medication, as it may affect the infant. Special attention is required when administering this medication to children and the elderly, and dosage adjustments and monitoring of conditions are essential. In case of overdose, symptoms such as coma, sedation, and myasthenia may occur, so if suspected, immediate emergency treatment should be sought. Follow the method of administration exactly as directed by the physician, and for extended-release formulations, do not crush or chew, but take them whole. Keep this medication out of the reach of children, and it is safer not to transfer it to another container.

Changes in liver function test results, serious liver damage, increased frequency of seizures, altered consciousness, drowsiness, coma, cognitive impairment, symptoms of dementia, Parkinson's disease, postural tremor, drowsiness, sedative effects, tremors, ataxia, headache, confusion, convulsions, delirium, hallucinations, dizziness, insomnia, anxiety, visual disturbances, nystagmus, double vision, inability to maintain fixed posture, spots in front of the eyes, speech disorders, sensory changes, excessive salivation, coma, hyperammonemia, consciousness disorder, suicidal impulses, suicidal behavior, depression, abnormal mood and behavior changes, increased appetite, abnormal weight gain, abdominal pain, loss of appetite, discomfort in the stomach area, constipation, stomatitis, nausea, abdominal pain, vomiting, diarrhea, pancreatitis, irregular menstruation, secondary amenorrhea, polycystic ovary syndrome, breast enlargement, galactorrhea, hyperandrogenemia, thyroid dysfunction, hair loss, hair discoloration, curly hair, skin rash, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythematous rash, myasthenia, decreased fibrinogen, decreased coagulation factor VIII, prolonged bleeding time, hyperglycinemia, anemia, macrocytosis, pancytopenia, leukopenia, thrombocytopenia, hemolytic anemia, megaloblastic anemia, granulocytopenia, eosinophilia, reduced platelet aggregation, lymphocytopenia, neutropenia, petechiae, contusions, hematoma formation, true bleeding, bone marrow failure, hearing loss, tinnitus, interstitial nephritis, nocturnal enuresis, Fanconi syndrome, hyperinsulinemia, decreased IGFBP-I, hypothermia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, angioedema, DRESS syndrome, erythema nodosum, vasculitis, allergic reactions, brain atrophy, dementia, hematuria, thirst, fatigue, epistaxis, generalized or localized edema, weight loss, weight gain, lupus-like syndrome, confusion, sedation, coma, myasthenia, decreased reflexes, areflexia, hypotension, miosis, cardiovascular diseases, respiratory diseases, cerebral edema, metabolic acidosis, hypokalemia, hypernatremia

This medication should be stored in a tightly closed container that blocks light and prevents air from entering. It is also important to store it at a cool temperature below 30 degrees Celsius.

Appearance

Yellow enteric-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle